Predictive biomarkers for checkpoint inhibitor immune-related adverse events

I Les, M Martinez, I Perez-Francisco, M Cabero… - Cancers, 2023 - mdpi.com
Simple Summary Immune-checkpoint inhibitors (ICIs) are increasingly used in the treatment
of cancer, but they cause immune-related adverse events (irAEs) in around 40% of patients …

Predicting and preventing immune checkpoint inhibitor toxicity: targeting cytokines

JH Kang, JA Bluestone, A Young - Trends in Immunology, 2021 - cell.com
Cancer immunotherapies can successfully activate immune responses towards certain
tumors. However, this can also result in the development of treatment-induced immune …

The NOD mouse beyond autoimmune diabetes

AM Aubin, F Lombard-Vadnais, R Collin… - Frontiers in …, 2022 - frontiersin.org
Autoimmune diabetes arises spontaneously in Non-Obese Diabetic (NOD) mice, and the
pathophysiology of this disease shares many similarities with human type 1 diabetes. Since …

Clinically relevant circulating protein biomarkers for type 1 diabetes: evidence from a two-sample Mendelian randomization study

N Yazdanpanah, M Yazdanpanah, Y Wang… - Diabetes …, 2022 - Am Diabetes Assoc
OBJECTIVE To identify circulating proteins influencing type 1 diabetes susceptibility using
Mendelian randomization (MR). RESEARCH DESIGN AND METHODS We used a large …

Berberine activates PPARδ and promotes gut microbiota-derived butyric acid to suppress hepatocellular carcinoma

JW Shou, PC Shaw - Phytomedicine, 2023 - Elsevier
Background Peroxisome proliferator-activated receptors (PPARs) are a family of ligand-
inducible transcription factors that govern various essential metabolic activities in the liver …

Immune fingerprint in diabetes: ocular surface and retinal inflammation

M Amorim, B Martins, R Fernandes - International Journal of Molecular …, 2023 - mdpi.com
Diabetes is a prevalent global health issue associated with significant morbidity and
mortality. Diabetic retinopathy (DR) is a well-known inflammatory, neurovascular …

Exploiting the role of T cells in the pathogenesis of Sjögren's syndrome for therapeutic treatment

Q An, J Zhao, X Zhu, B Yang, Z Wu, Y Su… - Frontiers in …, 2022 - frontiersin.org
Sjögrens syndrome (SS) is caused by autoantibodies that attack proprioceptive salivary and
lacrimal gland tissues. Damage to the glands leads to dry mouth and eyes and affects …

Self-renewing islet TCF1+ CD8 T cells undergo IL-27–controlled differentiation to become TCF1− terminal effectors during the progression of type 1 diabetes

AE Ciecko, DM Schauder, B Foda… - The Journal of …, 2021 - journals.aai.org
In type 1 diabetes (T1D) autoreactive CD8 T cells infiltrate pancreatic islets and destroy
insulin-producing β cells. Progression to T1D onset is a chronic process, which suggests …

IL-27 regulates NLRP3 inflammasome activation of MDSCs in experimental Sjögren's syndrome

X Xia, Q Long, J Zha, T Jiang, J Guo… - International …, 2023 - academic.oup.com
Excessive NOD-like receptor thermal protein domain associated protein 3 (NLRP3)
inflammasome activation has an important function in the pathogenesis of Sjögren's …

Impaired IL-27 signaling aggravates macrophage senescence and sensitizes premature ovarian insufficiency induction by high-fat diet

XY Zhang, CJ Wang, HH Shen, F Jiang, JL Shi… - … et Biophysica Acta (BBA …, 2024 - Elsevier
Premature ovarian insufficiency (POI) critically affects female reproductive health, with
obesity being a significant and recognized risk factor. Interleukin-27 (IL-27), known for its …